Alzamend Neuro (NASDAQ:ALZN – Get Free Report) will likely be announcing its earnings results before the market opens on ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Artificial intelligence (AI) is providing several tools in revolutionising treatment options in neuro-oncology, especially in ...

SOLANA BEACH, CALIFORNIA / ACCESS Newswire / February 26, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise ...

Memristors consume extremely little power and behave similarly to brain cells. Researchers have now introduced novel memristive that offer significant advantages: they are more robust, function across ...

Forward theme for biologics and drug delivery is to extend our lead. We believe that we are already the premier neuro cell and gene therapy delivery partner to more than 60 active biopharma ...

In the weightless environment of space, bones and muscles weaken due to reduced gravity, which can lead to bone density loss ...

They were able to identify a mechanism that increases the stability of proteins and thus favors neurodegenerative diseases such as Alzheimer's and Parkinson's disease. The results have been published ...

New brain-inspired hardware, architectures and algorithms could lead to more efficient, more capable forms of AI.

Ongoing Phase 1 and Phase 2 clinical programs continue to exhibit long-term durable remissions in hard-to-treat cancers, including glioblastoma ...